Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom D Bunney

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Structure (London, England : 1993)|February 27, 2018
Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone SystemTom D Bunney, Alison J Inglis, Domenico Sanfelice, et al.
The Biochemical Journal|September 26, 2025
Characterisation of an allosteric site in PLCγ enzymes and implications for development of their specific inhibitorsTom D Bunney, Hunter G Nyvall, Calum Macrae, et al.
Molecular Cell|April 28, 2009
Structural insights into formation of an active signaling complex between Rac and phospholipase C gamma 2Tom D Bunney, Olaniyi Opaleye, S Mark Roe, et al.
Molecular and Cellular Biology|January 20, 2011
Membrane environment exerts an important influence on rac-mediated activation of phospholipase Cγ2Katy L Everett, Anja Buehler, Tom D Bunney, et al.
Journal of Biophotonics|April 4, 2009
High speed unsupervised fluorescence lifetime imaging confocal multiwell plate reader for high content analysisClifford B Talbot, James McGinty, David M Grant, et al.
Molecular Cell|February 18, 2006
Structural and mechanistic insights into ras association domains of phospholipase C epsilonTom D Bunney, Richard Harris, Natalia Lamuño Gandarillas, et al.
Oncotarget|March 19, 2016
Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical useHarshnira Patani, Tom D Bunney, Nethaji Thiyagarajan, et al.
American Journal of Human Genetics|September 25, 2012
A hypermorphic missense mutation in PLCG2, encoding phospholipase Cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiencyQing Zhou, Geun-Shik Lee, Jillian Brady, et al.
Immunity|April 23, 2005
Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entryPhilipp Yu, Rainer Constien, Neil Dear, et al.
Journal of Clinical Immunology|July 17, 2020
Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 MutationsAndrea Martín-Nalda, Claudia Fortuny, Lourdes Rey, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Structure (London, England : 1993)|February 27, 2018
Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone SystemTom D Bunney, Alison J Inglis, Domenico Sanfelice, et al.
The Biochemical Journal|September 26, 2025
Characterisation of an allosteric site in PLCγ enzymes and implications for development of their specific inhibitorsTom D Bunney, Hunter G Nyvall, Calum Macrae, et al.
Molecular Cell|April 28, 2009
Structural insights into formation of an active signaling complex between Rac and phospholipase C gamma 2Tom D Bunney, Olaniyi Opaleye, S Mark Roe, et al.
Molecular and Cellular Biology|January 20, 2011
Membrane environment exerts an important influence on rac-mediated activation of phospholipase Cγ2Katy L Everett, Anja Buehler, Tom D Bunney, et al.
Journal of Biophotonics|April 4, 2009
High speed unsupervised fluorescence lifetime imaging confocal multiwell plate reader for high content analysisClifford B Talbot, James McGinty, David M Grant, et al.
Molecular Cell|February 18, 2006
Structural and mechanistic insights into ras association domains of phospholipase C epsilonTom D Bunney, Richard Harris, Natalia Lamuño Gandarillas, et al.
Oncotarget|March 19, 2016
Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical useHarshnira Patani, Tom D Bunney, Nethaji Thiyagarajan, et al.
American Journal of Human Genetics|September 25, 2012
A hypermorphic missense mutation in PLCG2, encoding phospholipase Cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiencyQing Zhou, Geun-Shik Lee, Jillian Brady, et al.
Immunity|April 23, 2005
Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entryPhilipp Yu, Rainer Constien, Neil Dear, et al.
Journal of Clinical Immunology|July 17, 2020
Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 MutationsAndrea Martín-Nalda, Claudia Fortuny, Lourdes Rey, et al.
Pageof 5